Although humans are living longer around the globe, life expectancy in the USA slipped recently to 78.6 years according to Center for Disease Control (CDC). After a half-century of improvements, middle-aged people are now more likely to die earlier than they were in 2011. Mortality rates for people aged 55-64 are increasing, while younger people and women are more often stricken. “Life expectancy gives us a snapshot of the nation’s overall health,” said Robert R. Redfield, Director CDC, “and these sobering statistics are a wakeup call that we are losing too many Americans, too early and too often, to conditions that are preventable.” Chronic disease is now the biggest threat to our longevity. The top 10 leading causes of morbidity include heart disease, cancer, unintentional injuries (this includes drug overdoses,) chronic lower respiratory disease, stroke, Alzheimer’s, and diabetes. While facing these challenges, life science companies can utilize Artificial Intelligence (AI) and Robotic Process Automation (RPA) to transform time to market for life-changing drugs and to raise life expectancy to a lofty old age.
Life science companies have a role to play helping people live better at any age
The CDC study finds that we are not just living shorter lives, we’re also living sicker lives. Of the 78 years we can expect to live, most of us only get to enjoy 67.7 of them free from illness and disability. Conventional medicine does have a role to play. Life science companies are rising to the challenge of the chronic disease epidemic by speeding up drug testing and changing the operational model while also redefining the role of the patient. New drug discoveries and alternative treatments are also fueling innovation. According to Tufts University Journal of Health Economics, bringing a new prescription medicine to the market is now estimated to cost drug companies $2.6 billion. However, new technology, such as AI-powered Digital Workers, are reducing costs while increasing speed-to-market for research and drug approval for fast-tracking pharmaceuticals to the patient.
Is there an advantage to having a digital workforce?
The emerging new digital workforce is ideal for life sciences companies because these AI-infused bots work better where there is lots of data to be handled, along with integrating information into multiple systems. For example, companies including Amgen, Boston Scientific, Cerner, and Lilly have all used AI and RPA when collecting, sorting, analyzing, and sharing data that’s key for bringing new drugs to the market faster. Digital Workers from the Bot Store can speed up data processing with uncanny accuracy leaving more time for humans to perform high-value tasks. Digital Workers are also helpful in engaging with patients, assisting in addressing adverse events and medical condition inquiries to provide the necessary support for behavior change as well as adherence to therapies. Specialized bots are also ideal for life science companies to extract specific information from multiple research documents.
Pursuit of functional medicine with advances in AI technology
Digital Workers are now well versed in a wide range of AI capabilities, such as:
Natural language processing: for understanding sentences and extracting meaning to convert into data
Speech recognition: ability to hear and interpret audio
Computer vision: ability to analyze images and scanned documents to extract data
Machine learning: leveraging large amounts of data passing through a system to teach machines including other bots about how to respond appropriately
Deep learning: based on artificial neural networks, trying to replicate the workings of the human brain
What’s the impact of a Digital Worker? Will you adopt this new innovation?
New Digital Workers provide a potentially game-changing technology for Life Sciences with their ability to read and interpret unstructured data and convert it into structured data while synching the information to various processing systems, saving time, resources, and lives.
Digital Workers have helped life science companies to:
Increase ROI by up to 628% by automating repetitive tasks in just 6 months
Reduce errors by 100% for several processes
Save time for humans to focus on creative and innovative work
liver a happier workplace in just 10 weeks using AI and RPA technology in combination
Innovative companies realize that AI-fueled processes are the future of life sciences. They are addressing the change management and culture change aspects of deploying a digital workforce. Do digital assistants mean easier work or job losses, and how does transformation affect employees? We’ll take a deeper dive into this topic in our next article.
There’s no biological cap to human longevity
We don’t have to accept living shorter, unhealthier lives. We can take control of our lives to lessen the risk of chronic disease and we can look to innovations from life science companies to slow down the chronic disease epidemic. Life science companies are unlocking the power of data to fuel innovation, bring drugs to market faster, and increase the span of human life.